Evidence map›Paper›PMID 35980511›Full record

ArticleCancer causes & control : CCC2022

Improving cervical cancer screening rates: a scoping review of resources and interventions.

Madyson L Popalis, Sarah I Ramirez, Kelsey M Leach, Marni E Granzow, Kelsey C Stoltzfus, Jennifer L Moss

Open access · greenAbstract readScoping Review
In one paragraph

Article in Cancer causes & control : CCC, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Research progress of metabolomics in cervical cancer.European journal of medical research · 2023
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Cervical Cancer Screening Utilization among Kidney Transplant Recipients, 2001 to 2018.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Madyson L PopalisDepartment of Family and Community Medicine, Penn State College of Medicine, Hershey, PA, USA.
Sarah I RamirezDepartment of Family and Community Medicine, Penn State College of Medicine, Hershey, PA, USA.
Kelsey M LeachDepartment of Family and Community Medicine, Penn State College of Medicine, Hershey, PA, USA.
Marni E GranzowDepartment of Family and Community Medicine, Penn State College of Medicine, Hershey, PA, USA.
Kelsey C StoltzfusDepartment of Family and Community Medicine, Penn State College of Medicine, Hershey, PA, USA.
Jennifer L MossDepartment of Family and Community Medicine, Penn State College of Medicine, Hershey, PA, USA. jmoss1@pennstatehealth.psu.edu.ORCID http://orcid.org/0000-0002-3794-1344
Penn State Milton S. Hershey Medical Center · US

Funding

Penn State Clinical and Translational Science InstituteUL1TR002014 · NCATS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI KRASCHNEWSKI, JENNIFER L. · 2016 to 2025
$33.7M
Overcoming barriers to cancer screening among women living in rural and segregated communitiesK22CA225705 · NCI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI MOSS, JENNIFER LINDSAY · 2019 to 2022
$629k
A novel use of web-based software to efficiently triage pre-surgical patients basR44TR000045 · NCATS · MEDSLEUTH, INC. · PI KALAMAS, ALICIA GRUBER · 2012 to 2012
$546k
NCATS NIH HHS R44 TR000045NCATS NIH HHS UL1 TR00045NCATS NIH HHS UL1 TR002014NCI NIH HHS K22 CA225705
6 · The paper itself

Abstract

introductionCervical cancer mortality can be prevented through early detection with screening methods such as Pap and high-risk human papillomavirus (hrHPV) tests; however, only 81% of women aged 21-65 are up-to-date on screening. Many interventions to increase cervical cancer screening have been implemented, but there is limited understanding about which intervention components are most successful.

methodsWe conducted a scoping review of existing literature and available resources for cervical cancer screening interventions to identify gaps in the research. We used t tests and correlations to identify associations among intervention components and effect sizes.

resultsOut of nine studies, the mean overall effect size for interventions was 11.3% increase in Pap testing for cervical cancer screening (range =  - 4-24%). Interventions that included community health workers or one-on-one interaction had the biggest effect size (p < 0.05). No associations with effect size were noted for literacy level, number of intervention components, or targeting by race/ethnicity.

conclusionsFuture interventions may include educational sessions with community health workers or one-on-one patient interaction to improve cervical cancer screening. Further research is needed to establish effect sizes for large-scale interventions and hrHPV screening interventions.

Indexed as

Papillomavirus InfectionsUterine Cervical NeoplasmsCervix UteriEarly Detection of CancerFemaleHumansMass ScreeningVaginal SmearsCervical cancerEarly detection of cancerEvidence-based medicineProgram evaluationReview

Identifiers

PMID35980511
PMCPMC10124066
OpenAlexW4292482499

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.